These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2942018)
1. [Phase I study with LH-RH agonist, ICI 118630]. Usami M; Kotake T; Sonoda T Hinyokika Kiyo; 1986 Mar; 32(3):493-501. PubMed ID: 2942018 [TBL] [Abstract][Full Text] [Related]
2. [Clinical effect of slow release (depot) formulation of the LH-RH analogue ICI 118630 (Zoladex) in patients with prostatic carcinoma]. Usami M; Kotake T; Matsuda M; Okajima E; Osafune M; Sonoda T Hinyokika Kiyo; 1987 Jan; 33(1):141-50. PubMed ID: 2953179 [TBL] [Abstract][Full Text] [Related]
3. Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer. Nicholson RI; Walker KJ Chemioterapia; 1985 Jun; 4(3):249-51. PubMed ID: 3161643 [TBL] [Abstract][Full Text] [Related]
4. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men. Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043 [TBL] [Abstract][Full Text] [Related]
5. Comparison of mammalian luteinizing hormone releasing hormone (LH-RH), and of an analog (ICI 118630), on luteinizing hormone and ovarian steroid (progesterone, oestradiol) secretions in laying hens. (Gallus domesticus). Guémené D; Williams JB Life Sci; 1986 Aug; 39(6):541-7. PubMed ID: 2942749 [TBL] [Abstract][Full Text] [Related]
6. The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer. Williams MR; Walker KJ; Turkes A; Blamey RW; Nicholson RI Br J Cancer; 1986 May; 53(5):629-36. PubMed ID: 2941044 [TBL] [Abstract][Full Text] [Related]
7. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men. Nillius SJ; Bergquist C; Wide L Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935 [TBL] [Abstract][Full Text] [Related]
8. [A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of goserelin acetate (Zoladex LA 10.8 mg depot)--outline of pre-clinical and clinical studies]. Tsukagoshi S Gan To Kagaku Ryoho; 2002 Sep; 29(9):1675-87. PubMed ID: 12355959 [TBL] [Abstract][Full Text] [Related]
9. The effect of injection and infusion of LH-RH on serum LH and FSH in normal males and in boys with delayed puberty. De Lange WE; Sluiter WJ; Van Zanten AK; Doorenbos H Neth J Med; 1974; 17(4-5):196-201. PubMed ID: 4619183 [No Abstract] [Full Text] [Related]
10. [Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen]. Usami M; Kotake T; Matsuda M; Okajima E; Osafune M; Akaza H; Niijima T; Aso Y; Araki T; Itatani H Hinyokika Kiyo; 1988 Oct; 34(10):1853-63. PubMed ID: 2977527 [TBL] [Abstract][Full Text] [Related]
11. Effect of Lh-Rh on antibody formation, sperm count and plasma levels of gonadotropins and testosterone in normal men. Stone SC; Jaramillo F; Kastin AJ; Arimura A; Vargas JR; Schally AV; Dickey RP Int J Fertil; 1974; 19(4):192-6. PubMed ID: 4376533 [TBL] [Abstract][Full Text] [Related]
12. Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer. Debruyne FM; Karthaus HF; Schröder FH; de Voogt HJ; de Jong FH; Klijn JG Prog Clin Biol Res; 1985; 185A():251-70. PubMed ID: 3929265 [No Abstract] [Full Text] [Related]
13. Effects of a single injection of a new depot formulation of an LH-releasing hormone agonist on spermatogenesis in adult rats. van Kroonenburgh MJ; Beck JL; Vemer HM; Rolland R; Thomas CM; Herman CJ J Endocrinol; 1986 Dec; 111(3):449-54. PubMed ID: 2949040 [TBL] [Abstract][Full Text] [Related]
14. Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer. Ahmann FR; Citrin DL; deHaan HA; Guinan P; Jordan VC; Kreis W; Scott M; Trump DL J Clin Oncol; 1987 Jun; 5(6):912-7. PubMed ID: 2953870 [TBL] [Abstract][Full Text] [Related]
15. Effects of a gonadotropin-releasing hormone agonist analog (ICI 118630) on endocrine functions of human testis in vivo and in vitro. Namiki M; Nonomura N; Nakamura M; Okuyama A; Sonoda T; Nishimune Y; Matsumoto K Fertil Steril; 1987 Dec; 48(6):1012-7. PubMed ID: 2960563 [TBL] [Abstract][Full Text] [Related]
16. Serum FSH and LH levels in men after administration of a long-acting LH-RH preparation. Laczi F; Julesz J; Bártfai G; Sas M; László FA Acta Med Acad Sci Hung; 1982; 39(3-4):125-31. PubMed ID: 6821016 [TBL] [Abstract][Full Text] [Related]
17. Gonadotropin release after administration of LH-RH during early follicular phase. Hanker JP; Ende U; Bohnet HG; Schneider HP Int J Fertil; 1980; 25(2):100-5. PubMed ID: 6117522 [TBL] [Abstract][Full Text] [Related]
18. Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue. West CP; Baird DT Clin Endocrinol (Oxf); 1987 Feb; 26(2):213-20. PubMed ID: 2959405 [TBL] [Abstract][Full Text] [Related]
19. Pituitary response to luteinizing hormone-releasing hormone analog at sea level and high altitudes. Paredes Suarez M; Varea Teran JR; Garces G; Avila C; Coy DH; Schally AV Obstet Gynecol; 1982 Jan; 59(1):52-7. PubMed ID: 6804897 [TBL] [Abstract][Full Text] [Related]
20. Prolactin and pituitary gonadotropin values and responses to acute luteinizing hormone-releasing hormone (LHRH) challenge in patients having long-term treatment with a depot LHRH analogue. Mahler C; Verhelst J; Chaban M; Denis L Cancer; 1991 Feb; 67(3):557-9. PubMed ID: 1824680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]